share_log

Apollomics | EFFECT: Others

SEC announcement ·  Apr 25 18:05
Summary by Futu AI
The United States Securities and Exchange Commission (SEC) has declared a Form F-3 filing by Apollomics Inc. effective as of April 24, 2024, at 5:00 PM. This notice of effectiveness allows Apollomics, a biopharmaceutical company, to potentially offer and sell securities in the future. The Form F-3, associated with file number 333-278430, is a registration statement used by foreign private issuers to register securities offerings in the U.S. market. The effectiveness of this filing is a regulatory step that enables Apollomics to access U.S. capital markets for potential fundraising activities.
The United States Securities and Exchange Commission (SEC) has declared a Form F-3 filing by Apollomics Inc. effective as of April 24, 2024, at 5:00 PM. This notice of effectiveness allows Apollomics, a biopharmaceutical company, to potentially offer and sell securities in the future. The Form F-3, associated with file number 333-278430, is a registration statement used by foreign private issuers to register securities offerings in the U.S. market. The effectiveness of this filing is a regulatory step that enables Apollomics to access U.S. capital markets for potential fundraising activities.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.